Identification of a family with van der Hoeve’s syndrome harboring a novel COL1A1 mutation and generation of patient-derived iPSC lines and CRISPR/Cas9-corrected isogenic iPSCs
Human Cell · 2024
DOI: 10.1007/s13577-024-01028-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Cell, 2024. Verfasst von SiJun Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Osteogenesis Imperfecta, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Major State Basic Research Development Program of China, Key Technologies Research and Development Program.
Abstract (Originalsprache)
Van der Hoeve's syndrome, also known as osteogenesis imperfecta (OI), is a genetic connective tissue disorder characterized by fragile, fracture-prone bone and hearing loss. The disease is caused by a gene mutation in one of the two type I collagen genes COL1A1 or COL1A2. In this study, we identified a novel frameshift mutation of the COL1A1 gene (c.1607delG) in a family with OI using whole-exome sequencing, bioinformatics analysis and Sanger sequencing. This mutation may lead to the deletion of a portion of exon 23 and the generation of a premature stop codon in the COL1A1 gene. To further investigate the impact of this mutation, we established two induced pluripotent stem cell (iPSC) lines from peripheral blood mononuclear cells of OI patients carrying a novel mutation in the COL1A1 gene. Osteoblasts (OB) derived from OI-iPSCs exhibited reduced production of type I collagen and diminished ability to differentiate into osteoblasts. Using a CRISPR-based homology-directed repair strategy, we corrected the OI disease-causing COL1A1 novel mutations in iPSCs generated from an affected individual. Our results demonstrated that the diminished expression of type I collagen and osteogenic potential were enhanced in OB induced from corrected OI-iPSCs compared to those from OI-iPSCs. Overall, our results provide new insights into the genetic basis of Van der Hoeve's syndrome and highlight the potential of iPSC technology for disease modeling and therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Otolaryngology Major Disease Research Key Laboratory of Hunan Province, Changsha, Hunan, China.
- Clinical Research Center for Pharyngolaryngeal Diseases and Voice Disorders in Hunan Province, Changsha, Hunan, China.
- Department of Otolaryngology-Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China. fengyong_hn@hotmail.com.
- Department of Otorhinolaryngology, The Affiliated Maternal and Child Health Hospital of Hunan Province, Hengyang Medical School, University of South China, Changsha, Hunan, China. fengyong_hn@hotmail.com.
- MOE Key Lab of Rare Pediatric Diseases and Institute of Otorhinolaryngology, Head and Neck Surgery, University of South China, Changsha, Hunan, China. fengyong_hn@hotmail.com.
Förderung
- National Natural Science Foundation of China
- Major State Basic Research Development Program of China
- Key Technologies Research and Development Program
- Key Research and Development Program of Hunan Province of China
- Fundamental Research Funds for Central Universities of the Central South University
- Postdoctoral Research Foundation of China
- Science and Technology Program of Hunan Province
- Natural Science Foundation of Hunan Province
Zitieren
APA
Li, S., Mei, L., He, C., Cai, X., Wu, H., Wu, X., Liu, Y., Feng, Y., & Song, J. (2024). Identification of a family with van der Hoeve’s syndrome harboring a novel COL1A1 mutation and generation of patient-derived iPSC lines and CRISPR/Cas9-corrected isogenic iPSCs. Human Cell. https://doi.org/10.1007/s13577-024-01028-3
Vancouver
Li S, Mei L, He C, Cai X, Wu H, Wu X, et al. Identification of a family with van der Hoeve’s syndrome harboring a novel COL1A1 mutation and generation of patient-derived iPSC lines and CRISPR/Cas9-corrected isogenic iPSCs. Human Cell. 2024. doi:10.1007/s13577-024-01028-3
BibTeX
@article{Li2024,
author = {Li, SiJun and Mei, Lingyun and He, Chufeng and Cai, Xinzhang and Wu, Hong and Wu, XueWen and Liu, Yalan and Feng, Yong and Song, Jian},
title = {Identification of a family with van der Hoeve’s syndrome harboring a novel COL1A1 mutation and generation of patient-derived iPSC lines and CRISPR/Cas9-corrected isogenic iPSCs},
journal = {Human Cell},
year = {2024},
doi = {10.1007/s13577-024-01028-3}
}
EUVIMED